Advertisement

Loading...

Greenway Greenhouse Cannabis Corporation

GWAY.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.17
$-0.01(-5.56%)
Canadian Market opens in 16h 33m

Greenway Greenhouse Cannabis Corporation Fundamental Analysis

Greenway Greenhouse Cannabis Corporation (GWAY.CN) shows moderate financial fundamentals with a PE ratio of -105.65, profit margin of -2.33%, and ROE of -2.15%. The company generates $0.0B in annual revenue with strong year-over-year growth of 71.10%.

Key Strengths

PEG Ratio-1.03

Areas of Concern

ROE-2.15%
Current Ratio0.59
We analyze GWAY.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 23.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
23.1/100

We analyze GWAY.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

GWAY.CN struggles to generate sufficient returns from assets.

ROA > 10%
-0.65%

Valuation Score

Excellent

GWAY.CN trades at attractive valuation levels.

PE < 25
-105.65
PEG Ratio < 2
-1.03

Growth Score

Excellent

GWAY.CN delivers strong and consistent growth momentum.

Revenue Growth > 5%
71.10%
EPS Growth > 10%
61.00%

Financial Health Score

Weak

GWAY.CN carries high financial risk with limited liquidity.

Debt/Equity < 1
1.59
Current Ratio > 1
0.59

Profitability Score

Weak

GWAY.CN struggles to sustain strong margins.

ROE > 15%
-214.72%
Net Margin ≥ 15%
-2.33%
Positive Free Cash Flow
No

Key Financial Metrics

Is GWAY.CN Expensive or Cheap?

P/E Ratio

GWAY.CN trades at -105.65 times earnings. This suggests potential undervaluation.

-105.65

PEG Ratio

When adjusting for growth, GWAY.CN's PEG of -1.03 indicates potential undervaluation.

-1.03

Price to Book

The market values Greenway Greenhouse Cannabis Corporation at 2.29 times its book value. This may indicate undervaluation.

2.29

EV/EBITDA

Enterprise value stands at 2.95 times EBITDA. This is generally considered low.

2.95

How Well Does GWAY.CN Make Money?

Net Profit Margin

For every $100 in sales, Greenway Greenhouse Cannabis Corporation keeps $-2.33 as profit after all expenses.

-2.33%

Operating Margin

Core operations generate 11.87 in profit for every $100 in revenue, before interest and taxes.

11.87%

ROE

Management delivers $-2.15 in profit for every $100 of shareholder equity.

-2.15%

ROA

Greenway Greenhouse Cannabis Corporation generates $-0.65 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.65%

Following the Money - Real Cash Generation

Operating Cash Flow

Greenway Greenhouse Cannabis Corporation generates limited operating cash flow of $-782.09K, signaling weaker underlying cash strength.

$-782.09K

Free Cash Flow

Greenway Greenhouse Cannabis Corporation generates weak or negative free cash flow of $-978.80K, restricting financial flexibility.

$-978.80K

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

GWAY.CN converts -4.32% of its market value into free cash.

-4.32%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-105.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.29

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.47

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.59

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.59

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.02

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How GWAY.CN Stacks Against Its Sector Peers

MetricGWAY.CN ValueSector AveragePerformance
P/E Ratio-105.6527.91 Better (Cheaper)
ROE-2.15%687.00% Weak
Net Margin-2.33%-45285.00% (disorted) Weak
Debt/Equity1.590.33 Weak (High Leverage)
Current Ratio0.592795.76 Weak Liquidity
ROA-0.65%-13557.00% (disorted) Weak

GWAY.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Greenway Greenhouse Cannabis Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

12.78%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

478.61%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ